• Publications
  • Influence
The United States Registry for Fibromuscular Dysplasia: Results in the First 447 Patients
Background— Fibromuscular dysplasia (FMD), a noninflammatory disease of medium-size arteries, may lead to stenosis, occlusion, dissection, and/or aneurysm. There has been little progress inExpand
  • 325
  • 36
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.
Worldwide, cardiovascular disease (CVD) is the largest single cause of death among women, accounting for one third of all deaths. In many countries, including the United States, more women than menExpand
  • 837
  • 32
  • PDF
Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association.
A link between oral health and cardiovascular disease has been proposed for more than a century. Recently, concern about possible links between periodontal disease (PD) and atherosclerotic vascularExpand
  • 646
  • 25
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical
Jonathan L. Halperin, MD, FACC, FAHA, Chair Glenn N. Levine, MD, FACC, FAHA, Chair-Elect Sana M. Al-Khatib, MD, MHS, FACC, FAHA Kim K. Birtcher, PharmD, MS, AACC Biykem Bozkurt, MD, PhD, FACC,Expand
  • 555
  • 20
Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association.
Fibromuscular dysplasia (FMD) is nonatherosclerotic, noninflammatory vascular disease that may result in arterial stenosis, occlusion, aneurysm, or dissection.1–3 The cause of FMD and its prevalenceExpand
  • 248
  • 19
Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart
2011 Writing Group Members Thom W. Rooke, MD, FACC, Chair† Alan T. Hirsch, MD, FACC, Vice Chair* Sanjay Misra, MD, FAHA, FSIR, Vice Chair*‡ Anton N. Sidawy, MD, MPH, FACS, Vice Chair§ Joshua A.Expand
  • 174
  • 17
  • PDF
2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology
Keeping pace with the stream of new data and evolving evidence on which guideline recommendations are based is an ongoing challenge to timely development of clinical practice guidelines. In an effortExpand
  • 550
  • 10
  • PDF
2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary
Developed in Collaboration With the American Association of Cardiovascular and Pulmonary Rehabilitation, Inter-Society Consensus for the Management of Peripheral Arterial Disease, Society forExpand
  • 100
  • 8
  • PDF
Pharmacomechanical Catheter‐Directed Thrombolysis for Deep‐Vein Thrombosis
Background The post‐thrombotic syndrome frequently develops in patients with proximal deep‐vein thrombosis despite treatment with anticoagulant therapy. Pharmacomechanical catheter‐directedExpand
  • 216
  • 6
  • PDF